An Eli Lilly spokesperson told Pharmaceutical Technology: “[The telehealth companies] are deceptively marketing knockoff tirzepatide as safe and effective for ‘cosmetic weight loss ...

Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its diabetes treatment Mounjaro, escalating its battle against unauthorized ...

Eli Lilly has also submitted this modified schedule for regulatory review in other countries. Kisunla has been approved in Australia, Bahrain, Brazil, China, Japan, Kuwait, Mexico, Qatar ...

Eli Lilly (LLY 0.34%) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following recent clinical wins, the company may even be taking the lead ahead of ...